CoChat
Sign Up
Cited by 147

The DOI matches its Crossref record.

Potential of Chitosan and its derivatives for controlled drug release applications – A review

Safdar, Rizwan, Omar, Abdul Aziz, Arunagiri, Appusami, Regupathi, Iyyasami, Thanabalan, Murugesan·2019·Journal of Drug Delivery Science and Technology
DOI 10.1016/j.jddst.2018.10.020
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1016/j.jddst.2018.10.020

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 167

  1. Kost, 2012, Responsive polymeric delivery systems, Adv. Drug Deliv. Rev., 64, 327, 10.1016/j.addr.2012.09.014 · DOI
  2. Kikuchi, 2002, Pulsatile drug release control using hydrogels, Adv. Drug Deliv. Rev., 54, 53, 10.1016/S0169-409X(01)00243-5 · DOI
  3. Gabizon, 2006, Reduced toxicity and superior therapeutic activity of a mitomycin C lipid–based prodrug incorporated in pegylated liposomes, Clin. Canc. Res., 12, 1913, 10.1158/1078-0432.CCR-05-1547 · DOI
  4. Baker, 2009, Docetaxel–related side effects and their management, Eur. J. Oncol. Nurs., 13, 49, 10.1016/j.ejon.2008.10.003 · DOI
  5. Tarr, 1987, A new parenteral vehicle for the administration of some poorly soluble anti–cancer drugs, PDA J. Pharm. Sci. Technol., 41, 31
  6. Weiss, 1990, Hypersensitivity reactions from taxol, J. Clin. Oncol., 8, 1263, 10.1200/JCO.1990.8.7.1263 · DOI
  7. Puglia, 2017, Modern drug delivery strategies applied to natural active compounds, Expet Opin. Drug Deliv., 14, 755, 10.1080/17425247.2017.1234452 · DOI
  8. Ajorlou, 2017, Trends on polymer–and lipid–based nanostructures for parenteral drug delivery to tumors, Cancer Chemother. Pharmacol., 1
  9. Solari, 2017, Sublingual tacrolimus administration provides similar drug exposure to per‐oral route employing lower doses in liver transplantation: a pilot study, Aliment. Pharmacol. Ther., 45, 1225, 10.1111/apt.14022 · DOI
  10. Dutta, 2017, Templated self–assembly of a covalent polymer network for intracellular protein delivery and traceless release, J. Am. Chem. Soc., 139, 5676, 10.1021/jacs.7b01214 · DOI
  11. Pelras, 2017, A ‘grafting from’ approach to polymer nanorods for pH–triggered intracellular drug delivery, Polym, 112, 244, 10.1016/j.polymer.2017.02.001 · DOI
  12. Santos, 2012, Polymeric nanoparticles to control the differentiation of neural stem cells in the subventricular zone of the brain, ACS Nano, 6, 10463, 10.1021/nn304541h · DOI · Paper page
  13. Khafagy, 2007, Current challenges in non–invasive insulin delivery systems: a comparative review, Adv. Drug Deliv. Rev., 59, 1521, 10.1016/j.addr.2007.08.019 · DOI
  14. Pridgen, 2014, Polymeric nanoparticle technologies for oral drug delivery, Clin. Gastroenterol. Hepatol., 12, 1605, 10.1016/j.cgh.2014.06.018 · DOI
  15. Mei, 2013, Pharmaceutical nanotechnology for oral delivery of anticancer drugs, Adv. Drug Deliv. Rev., 65, 880, 10.1016/j.addr.2012.11.005 · DOI
  16. Teague, 2017, How to identify and eliminate compounds with a risk of high clinical dose during the early phase of lead optimisation in drug discovery, Eur. J. Pharmaceut. Sci., 110, 37, 10.1016/j.ejps.2017.02.017 · DOI
  17. Martin–Vicente, 2017, (Does a triple combination have better activity than double combinations against multiresistant fungi, Experimental in vitro evaluation, Int. J. Antimicrob. Agents, 49, 422, 10.1016/j.ijantimicag.2016.12.015 · DOI
  18. Kayser, 2003, Formulation and biopharmaceutical issues in the development of drug delivery systems for antiparasitic drugs, Parasitol. Res., 90, S63, 10.1007/s00436-002-0769-2 · DOI
  19. Mitragotri, 2012, Materials for drug delivery: innovative solutions to address complex biological hurdles, Adv. Mater., 24, 3717, 10.1002/adma.201202080 · DOI
  20. Papadimitriou, 2016, Smart polymeric nanoparticles as emerging tools for imaging—the parallel evolution of materials, Chem. Eur J., 22, 3612, 10.1002/chem.201502610 · DOI
  21. Mura, 2013, Stimuli–responsive nanocarriers for drug delivery, Nat. Mater., 12, 991, 10.1038/nmat3776 · DOI · Paper page
  22. Ajorlou, 2017, Trends on polymer–and lipid–based nanostructures for parenteral drug delivery to tumors, Cancer Chemother. Pharmacol., 1
  23. Lam, 2018, Antimicrobial polymeric nanoparticles, Prog. Polym. Sci., 76, 40, 10.1016/j.progpolymsci.2017.07.007 · DOI
  24. Kittur, 2003, Low molecular weight chitosans—preparation by depolymerization with Aspergillus Niger pectinase, and characterization, Carbohydr. Res., 338, 1283, 10.1016/S0008-6215(03)00175-7 · DOI
  25. Agnihotri, 2004, Recent advances on chitosan–based micro–and nanoparticles in drug delivery, J. Contr. Release, 100, 5, 10.1016/j.jconrel.2004.08.010 · DOI
  26. Krajewska, 2005, Membrane–based processes performed with use of chitin/chitosan materials, Separ. Purif. Technol., 41, 305, 10.1016/j.seppur.2004.03.019 · DOI
  27. Sahariah, 2017, Antimicrobial chitosan and chitosan derivatives: a review of the structure–activity relationship, Biomacromolecules, 18, 3846, 10.1021/acs.biomac.7b01058 · DOI
  28. Liu, 2017, Preparation and characterization of chitosan by a novel deacetylation approach using glycerol as green reaction solvent, ACS Sustain. Chem. Eng., 5, 4690, 10.1021/acssuschemeng.7b00050 · DOI
  29. Vunain, 2017, Fundamentals of chitosan for biomedical applications, In Chitosan Based Biomaterials, 1, 3, 10.1016/B978-0-08-100230-8.00001-7 · DOI
  30. Garcia-Fuentes, 2012, Chitosan-based drug nanocarriers: where do we stand, J. Contr. Release, 161, 496, 10.1016/j.jconrel.2012.03.017 · DOI
  31. Liu, 2017, Synthesis, characterization, bioactivity and potential application of phenolic acid grafted chitosan: a review, Carbohydr. Polym., 174, 999, 10.1016/j.carbpol.2017.07.014 · DOI
  32. Schipper, 1997, Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement, Pharm. Res., 14, 923, 10.1023/A:1012160102740 · DOI
  33. Casettari, 2014, Chitosan in nasal delivery systems for therapeutic drugs, J. Contr. Release, 190, 189, 10.1016/j.jconrel.2014.05.003 · DOI
  34. Benediktsdóttir, 2014, Challenges in evaluation of chitosan and trimethylated chitosan (TMC) as mucosal permeation enhancers: from synthesis to in vitro application, J. Contr. Release, 173, 18, 10.1016/j.jconrel.2013.10.022 · DOI
  35. Papadimitriou, 2008, Chitosan nanoparticles loaded with dorzolamide and pramipexole, Carbohydr. Polym., 73, 44, 10.1016/j.carbpol.2007.11.007 · DOI
  36. Elgadir, 2015, Impact of chitosan composites and chitosan nanoparticle composites on various drug delivery systems: a review, J. Food Drug Anal., 23, 619, 10.1016/j.jfda.2014.10.008 · DOI
  37. Malmo, 2011, Effect of chitosan chain architecture on gene delivery: comparison of self–branched and linear chitosans, Biomacromolecules, 12, 721, 10.1021/bm1013525 · DOI
  38. Kong, 2010, Antimicrobial properties of chitosan and mode of action: a state of the art review, Int. J. Food Microbiol., 144, 51, 10.1016/j.ijfoodmicro.2010.09.012 · DOI · Paper page
  39. Ahmad, 2017, Chitosan centered bionanocomposites for medical specialty and curative applications: a review, Int. J. Pharm., 529, 200, 10.1016/j.ijpharm.2017.06.079 · DOI
  40. Gan, 2007, Chitosan nanoparticle as protein delivery Carrier—systematic examination of fabrication conditions for efficient loading and release, Colloids Surf., B, 59, 24, 10.1016/j.colsurfb.2007.04.009 · DOI
  41. Bernkop-Schnürch, 2012, Chitosan-based drug delivery systems, Eur. J. Pharm. Biopharm., 81, 463, 10.1016/j.ejpb.2012.04.007 · DOI
  42. Boonsongrit, 2008, Characterization of drug–chitosan interaction by 1H NMR, FTIR and isothermal titration calorimetry, Eur. J. Pharm. Biopharm., 69, 388, 10.1016/j.ejpb.2007.11.008 · DOI
  43. Calvo, 1997, Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines, Pharm. Res., 14, 1431, 10.1023/A:1012128907225 · DOI
  44. Boonsongrit, 2006, Chitosan drug binding by ionic interaction, Eur. J. Pharm. Biopharm., 62, 267, 10.1016/j.ejpb.2005.09.002 · DOI
  45. Luo, 2014, Recent development of chitosan-based polyelectrolyte complexes with natural polysaccharides for drug delivery, Int. J. Biol. Macromol., 64, 353, 10.1016/j.ijbiomac.2013.12.017 · DOI
  46. Keen, 2007, Interactions between alginate and chitosan biopolymers characterized using FTIR and XPS, Biomacromolecules, 8, 2533, 10.1021/bm070014y · DOI
  47. Katarina, 2006, Synthesis of a chitosan–based chelating resin and its application to the selective concentration and ultratrace determination of silver in environmental water samples, Anal. Chim. Acta, 558, 246, 10.1016/j.aca.2005.11.010 · DOI
  48. Zhang, 2017, Oxidation–mediated chitosan as additives for creation of chitosan aerogels with diverse three–dimensional interconnected skeletons, Appl. Surf. Sci., 396, 1220, 10.1016/j.apsusc.2016.11.116 · DOI
  49. Xu, 2003, Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles, Int. J. Pharm., 250, 215, 10.1016/S0378-5173(02)00548-3 · DOI
  50. Huei, 1996, Effect of molecular weight of chitosan with the same degree of deacetylation on the thermal, mechanical, and permeability properties of the prepared membrane, Carbohydr. Polym., 29, 353, 10.1016/S0144-8617(96)00007-0 · DOI
  51. Kasaai, 2000, Intrinsic viscosity–molecular weight relationship for chitosan, J. Polym. Sci., Polym. Phys. Ed., 38, 2591, 10.1002/1099-0488(20001001)38:19<2591::AID-POLB110>3.0.CO;2-6 · DOI
  52. Kume, 1964, Molecular weight measurement by vapor pressure osmometer, Macromol. Chem. Phys., 79, 1, 10.1002/macp.1964.020790101 · DOI
  53. Umoren, 2016, Polymer characterization: polymer molecular weight determination, Polymer Science: Research Advances, practical applications and educational aspects, 412
  54. Page, 1964, End-group Analysis and number-average molecular weight determination of some polyalkylene glycols and glycol polyesters using nuclear magnetic resonance spectroscopy, Anal. Chem., 36, 1981, 10.1021/ac60216a029 · DOI
  55. Liu, 1999, Employing MALDI-MS on poly (alkylthiophenes): analysis of molecular weights, molecular weight distributions, end-group structures, and end-group modifications, Macromolecules, 32, 5777, 10.1021/ma9905324 · DOI
  56. Paradossi, 1982, Light scattering study of a series of xanthan fractions in aqueous solution, Macromolecules, 15, 874, 10.1021/ma00231a035 · DOI
  57. Cleland, 1970, Ionic polysaccharides. III. Dilute solution properties of hyaluronic acid fractions, Biopolymers, 9, 799, 10.1002/bip.1970.360090706 · DOI
  58. Debye, 1947, Molecular-weight determination by light scattering, J. Phys. Chem., 51, 18, 10.1021/j150451a002 · DOI
  59. Nguyen, 2009, Improved reproducibility in the determination of the molecular weight of chitosan by analytical size exclusion chromatography, Carbohydr. Polym., 75, 528, 10.1016/j.carbpol.2008.08.013 · DOI
  60. Fiamingo, 2016, Extensively deacetylated high molecular weight chitosan from the multistep ultrasound-assisted deacetylation of beta-chitin, Ultrason. Sonochem., 32, 79, 10.1016/j.ultsonch.2016.02.021 · DOI
  61. Neira‐Velázquez, 2013, Polymer molecular weight measurement, handbook of polymer synthesis, Characterization, and Processing, 355
  62. Moore, 1965, Gel permeation chromatography. II, the nature of the separation, J. Polym. Sci., 8, 233
  63. Boonyo, 2017, Preparation and characterization of particles from chitosan with different molecular weights and their trimethyl chitosan derivatives for nasal immunization, J. Met. Mater. Min., 18
  64. Sun, 2017, Synthesis, characterization, and antimicrobial activities of sulfonated chitosan, Carbohydr. Polym., 155, 321, 10.1016/j.carbpol.2016.08.069 · DOI
  65. Dueramae, 2017, Self-assembly of acetylated dextran with various acetylation degrees in aqueous solutions: studied by light scattering, Carbohydr. Polym., 159, 171, 10.1016/j.carbpol.2016.12.026 · DOI
  66. Ito, 2018, Chitosan gel sheet containing drug carriers with controllable drug-release properties, Colloids. Surf. B, 163, 257, 10.1016/j.colsurfb.2017.12.054 · DOI
  67. Zheng, 2017, PCL-based thermo-gelling polymers for in vivo delivery of chemotherapeutics to tumors, Mater. Sci. Eng. C, 74, 110, 10.1016/j.msec.2017.02.005 · DOI
  68. Silva, 2018, Proposed molecular model for electrostatic interactions between insulin and chitosan. Nano-complexation and activity in cultured cells, Colloids. Surf. A Physicochem. Eng. Aspects, 537, 425, 10.1016/j.colsurfa.2017.10.040 · DOI
  69. João, 2017, Chitosan Inverted Colloidal Crystal scaffolds: influence of molecular weight on structural stability, Mater. Lett., 193, 50, 10.1016/j.matlet.2017.01.096 · DOI
  70. Kadouche, 2017, Low cost chitosan biopolymer for environmental use made from abundant shrimp wastes, Waste Biomass Valor, 8, 401, 10.1007/s12649-016-9593-2 · DOI
  71. Wang, 2017, Low molecular weight chitosan is an effective antifungal agent against Botryosphaeria sp. and preservative agent for pear (Pyrus) fruits, Int. J. Biol. Macromol., 95, 1135, 10.1016/j.ijbiomac.2016.10.105 · DOI
  72. Younes, 2014, Influence of acetylation degree and molecular weight of homogeneous chitosans on antibacterial and antifungal activities, Int. J. Food Microbiol., 185, 57, 10.1016/j.ijfoodmicro.2014.04.029 · DOI
  73. Viel, 2003, Diffusion-ordered NMR spectroscopy: a versatile tool for the molecular weight determination of uncharged polysaccharides, Biomacromolecules, 4, 1843, 10.1021/bm0342638 · DOI
  74. Iqbal, 2017, Enzymatic and acidic degradation of high molecular weight dextran into low molecular weight and its characterizations using novel Diffusion-ordered NMR spectroscopy, Int. J. Biol. Macromol., 103, 744, 10.1016/j.ijbiomac.2017.05.073 · DOI
  75. Wang, 2006, Protonation constants of chitosan with different molecular weight and degree of deacetylation, Carbohydr. Polym., 65, 194, 10.1016/j.carbpol.2006.01.001 · DOI
  76. Feng, 2013, Chitosan/o–carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation, Int. J. Pharm., 457, 158, 10.1016/j.ijpharm.2013.07.079 · DOI
  77. Bekale, 2015, Effect of polymer molecular weight on chitosan–protein interaction, Colloids Surf., B, 125, 309, 10.1016/j.colsurfb.2014.11.037 · DOI
  78. Papadimitriou, 2012, Chitosan-g-PEG nanoparticles ionically crosslinked with poly (glutamic acid) and tripolyphosphate as protein delivery systems, Int. J. Pharm., 430, 318, 10.1016/j.ijpharm.2012.04.004 · DOI
  79. Wu, 2005, Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate, Int. J. Pharm., 295, 235, 10.1016/j.ijpharm.2005.01.042 · DOI
  80. Prabaharan, 2015, Chitosan–based nanoparticles for tumor–targeted drug delivery, Int. J. Biol. Macromol., 72, 1313, 10.1016/j.ijbiomac.2014.10.052 · DOI
  81. Zhang, 2002, Properties and biocompatibility of chitosan films modified by blending with PEG, Biomaterials, 23, 2641, 10.1016/S0142-9612(01)00403-3 · DOI
  82. Bernela, 2016, Enhancement of anti–inflammatory activity of glycyrrhizic acid by encapsulation in chitosan–katira gum nanoparticles, Eur. J. Pharm. Biopharm., 105, 141, 10.1016/j.ejpb.2016.06.003 · DOI
  83. Gan, 2005, Modulation of surface charge, particle size and morphological properties of chitosan–TPP nanoparticles intended for gene delivery, Colloids Surf., B, 44, 65, 10.1016/j.colsurfb.2005.06.001 · DOI
  84. Tsai, 2011, The storage stability of chitosan/tripolyphosphate nanoparticles in a phosphate buffer, Carbohydr. Polym., 84, 756, 10.1016/j.carbpol.2010.04.040 · DOI
  85. Antoniou, 2015, Physicochemical and morphological properties of size-controlled chitosan–tripolyphosphate nanoparticles, Colloids Surf. A Physicochem. Eng. Aspects, 465, 137, 10.1016/j.colsurfa.2014.10.040 · DOI
  86. Chinta, 2009, Spray–dried chitosan as a direct compression tableting excipients, Drug Dev. Ind. Pharm., 35, 43, 10.1080/03639040802149053 · DOI
  87. Khlibsuwan, 2016, Chitosan–clay matrix tablets for sustained–release drug delivery: effect of chitosan molecular weight and lubricant, J. Drug Deliv. Sci. Technol., 35, 303, 10.1016/j.jddst.2016.08.003 · DOI
  88. Huanbutta, 2011, Swelling kinetics of spray–dried chitosan acetate assessed by magnetic resonance imaging and their relation to drug release kinetics of chitosan matrix tablets, Eur. J. Pharm. Biopharm., 77, 320, 10.1016/j.ejpb.2010.11.019 · DOI
  89. Bansal, 2011, Applications of chitosan and chitosan derivatives in drug delivery, Adv. Biol. Res., 5, 28
  90. Qi, 2004, Preparation and antibacterial activity of chitosan nanoparticles, Carbohydr. Res., 339, 2693, 10.1016/j.carres.2004.09.007 · DOI
  91. Dos Santos, 2009, Determination of deacetylation degree of chitosan: a comparison between conductometric titration and CHN elemental analysis, Carbohydr. Res., 344, 2591, 10.1016/j.carres.2009.08.030 · DOI
  92. Zhang, 2011, Determination of the degree of deacetylation of chitosan by potentiometric titration preceded by enzymatic pretreatment, Carbohydr. Polym, 83, 813, 10.1016/j.carbpol.2010.08.058 · DOI
  93. Jiang, 2003, A new linear potentiometric titration method for the determination of deacetylation degree of chitosan, Carbohydr. Polym., 54, 457, 10.1016/j.carbpol.2003.05.004 · DOI
  94. Kasaai, 2009, Various methods for determination of the degree of N-acetylation of chitin and chitosan: a review, J. Agric. Food Chem., 57, 1667, 10.1021/jf803001m · DOI
  95. Fernandez-Megia, 2005, Optimal routine conditions for the determination of the degree of acetylation of chitosan by 1H-NMR, Carbohydr. Polym., 61, 155, 10.1016/j.carbpol.2005.04.006 · DOI
  96. Heux, 2000, Solid state NMR for determination of degree of acetylation of chitin and chitosan, Biomacromolecules, 1, 746, 10.1021/bm000070y · DOI
  97. Balázs, 2007, Limitations of pH-potentiometric titration for the determination of the degree of deacetylation of chitosan, Carbohydr. Res., 342, 124, 10.1016/j.carres.2006.11.016 · DOI
  98. Hattori, 1999, Colloidal titration of chitosan and critical unit of chitosan to the potentiometric colloidal titration with poly (vinyl sulfate) using toluidine blue as indicator, Bull. Chem. Soc. Jpn., 72, 37, 10.1246/bcsj.72.37 · DOI
  99. de Alvarenga, 2010, An approach to understanding the deacetylation degree of chitosan, Carbohydr. Polym., 80, 1155, 10.1016/j.carbpol.2010.01.037 · DOI
  100. Niola, 1993, A rapid method for the determination of the degree of N-acetylation of chitin-chitosan samples by acid hydrolysis and HPLC, Carbohydr. Res., 238, 1, 10.1016/0008-6215(93)87001-9 · DOI
  101. Yan, 2012, Chitosan analysis using acid hydrolysis and HPLC/UV, Carbohydr. Polym., 87, 1774, 10.1016/j.carbpol.2011.09.091 · DOI
  102. Han, 2015, Determination of the degree of acetylation and the distribution of acetyl groups in chitosan by HPLC analysis of nitrous acid degraded and PMP labeled products, Carbohydr. Res., 413, 75, 10.1016/j.carres.2015.03.002 · DOI
  103. Sato, 1998, Determination of the degree of acetylation of chitin/chitosan by pyrolysis-gas chromatography in the presence of oxalic acid, Anal. Chem., 70, 7, 10.1021/ac9706685 · DOI
  104. Hirai, 1991, Determination of degree of deacetylation of chitosan by 1 H NMR spectroscopy, Polym. Bull., 26, 87, 10.1007/BF00299352 · DOI
  105. Lavertu, 2003, A validated 1H NMR method for the determination of the degree of deacetylation of chitosan, J. Pharmaceut. Biomed. Anal., 32, 1149, 10.1016/S0731-7085(03)00155-9 · DOI
  106. Chaouat, 2017, Green microparticles based on a chitosan/lactobionic acid/linoleic acid association. Characterisation and evaluation as a new Carrier system for cosmetics, J. Microencapsul., 34, 162, 10.1080/02652048.2017.1311956 · DOI
  107. King, 2017, Measuring the purity of chitin with a clean, quantitative solid-state NMR method, ACS Sustain. Chem. Eng., 5, 8011, 10.1021/acssuschemeng.7b01589 · DOI
  108. Zhang, 2018, Tunable pH-responsive Chitosan-Poly (acrylic acid) electrospun fibers, Biomacromolecules, 19, 588, 10.1021/acs.biomac.7b01672 · DOI
  109. Ma, 2017, Stability and binding affinity of DNA/chitosan complexes by polyanion competition, Carbohydr. Polym., 176, 167, 10.1016/j.carbpol.2017.08.002 · DOI
  110. Taşkın, 2014, The effect of degree of deacetylation on the radiation induced degradation of chitosan, Radiat. Phys. Chem., 94, 236, 10.1016/j.radphyschem.2013.04.007 · DOI
  111. Yang, 2010, The effect of the degree of deacetylation of chitosan nanoparticles and its characterization and encapsulation efficiency on drug delivery, Polym. Technol. Eng., 49, 1292, 10.1080/03602559.2010.482076 · DOI
  112. Koo, 2013, Enhanced drug–loading and therapeutic efficacy of hydrotropic oligomer–conjugated glycol chitosan nanoparticles for tumor–targeted paclitaxel delivery, J. Contr. Release, 172, 823, 10.1016/j.jconrel.2013.08.297 · DOI
  113. Fan, 2012, Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique, Colloids, Surf. B, 90, 21, 10.1016/j.colsurfb.2011.09.042 · DOI
  114. Shu, 2002, The influence of multivalent phosphate structure on the properties of ionically cross-linked chitosan films for controlled drug release, Eur. J. Pharm. Biopharm., 54, 235, 10.1016/S0939-6411(02)00052-8 · DOI
  115. Hu, 2008, Optimization of fabrication parameters to produce chitosan− tripolyphosphate nanoparticles for delivery of tea catechins, J. Agric. Food Chem., 56, 7451, 10.1021/jf801111c · DOI
  116. Rampino, 2013, Chitosan nanoparticles: preparation, size evolution and stability, Int. J. Pharm., 455, 219, 10.1016/j.ijpharm.2013.07.034 · DOI
  117. Rázga, 2016, Preparation of chitosan-TPP sub-micron particles: critical evaluation and derived recommendations, Carbohydr. Polym., 151, 488, 10.1016/j.carbpol.2016.05.092 · DOI
  118. Sipoli, 2015, Scalable production of highly concentrated chitosan/TPP nanoparticles in different pHs and evaluation of the in vitro transfection efficiency, Biochem. Eng. J., 94, 65, 10.1016/j.bej.2014.11.008 · DOI
  119. Bhumkar, 2006, Studies on effect of pH on cross–linking of chitosan with sodium tripolyphosphate: a technical note, Aaps PharmSciTech, 7, E138, 10.1208/pt070250 · DOI
  120. Zhang, 2013, Preparation and in vitro and in vivo characterization of cyclosporin A–loaded, PEGylated chitosan–modified, lipid–based nanoparticles, Int. J. Nanomed., 8, 601
  121. Tang, 2017, Dimethyl-β-cyclodextrin/salazosulfapyridine inclusion complex-loaded chitosan nanoparticles for sustained release, Carbohydr. Polym., 156, 215, 10.1016/j.carbpol.2016.09.038 · DOI
  122. Chen, 2017, Manipulation of pH–Sensitive interactions between podophyllotoxin–chitosan for enhanced controlled drug release, Int. J. Biol. Macromol., 95, 451, 10.1016/j.ijbiomac.2016.11.053 · DOI
  123. Bernkop–Schnürch, 2012, Chitosan–based drug delivery systems, Eur. J. Pharm. Biopharm., 81, 463, 10.1016/j.ejpb.2012.04.007 · DOI
  124. Fonseca–Santos, 2017, An overview of carboxymethyl derivatives of chitosan: their use as biomaterials and drug delivery systems, Mater. Sci. Eng., 77, 1349, 10.1016/j.msec.2017.03.198 · DOI
  125. Anitha, 2012, Curcumin–loaded N, O–carboxymethyl chitosan nanoparticles for cancer drug delivery, J. Biomater. Sci. Polym. Ed., 23, 1381, 10.1163/092050611X581534 · DOI
  126. Bai, 2017, Systematic investigation of fabrication conditions of nanocarrier based on carboxymethyl chitosan for sustained release of insulin, Int. J. Biol. Macromol., 102, 468, 10.1016/j.ijbiomac.2017.03.181 · DOI
  127. Zhang, 2017, Comparison in docetaxel-loaded nanoparticles based on three different carboxymethyl chitosans, Int. J. Biol. Macromol., 101, 1012, 10.1016/j.ijbiomac.2017.03.195 · DOI
  128. Ahmadi Nasab, 2017, Delivery of curcumin by a pH–responsive chitosan mesoporous silica nanoparticles for cancer treatment, Artif. Cells Nanomed. Biotechnol., 75
  129. Esfandiarpour–Boroujeni, 2017, Fabrication and study of curcumin loaded nanoparticles based on folate–chitosan for breast cancer therapy application, Carbohydr. Polym., 168, 14, 10.1016/j.carbpol.2017.03.031 · DOI
  130. Yu, 2017, Effects of chitosan molecular weight on the physical and dissolution characteristics of amorphous curcumin–chitosan nanoparticle complex, Drug Dev. Ind. Pharm., 1
  131. Yuan, 2010, Controlled and extended drug release behavior of chitosan–based nanoparticle Carrier, Acta Biomater., 6, 1140, 10.1016/j.actbio.2009.08.027 · DOI
  132. Wang, 2017, 3–Carboxyphenylboronic acid–modified carboxymethyl chitosan nanoparticles for improved tumor targeting and inhibitory, Eur. J. Pharm. Biopharm., 113, 168, 10.1016/j.ejpb.2016.12.034 · DOI
  133. Yang, 2016, Carboxymethyl chitosan-mediated synthesis of hyaluronic acid-targeted graphene oxide for cancer drug delivery, Carbohydr. Polym., 135, 72, 10.1016/j.carbpol.2015.08.058 · DOI
  134. Zhang, 2016, Preparation of polyelectrolyte complex nanoparticles of chitosan and poly (2–acry1amido–2–methylpropanesulfonic acid) for doxorubicin release, Mater. Sci. Eng. C, 58, 724, 10.1016/j.msec.2015.09.044 · DOI
  135. Trickler, 2008, A novel nanoparticle formulation for sustained paclitaxel delivery, AAPS PharmSciTech, 9, 486, 10.1208/s12249-008-9063-7 · DOI
  136. Chen, 2004, Chitosan-dextran sulfate nanoparticles for delivery of an anti-angiogenesis peptide, Lett. Pept. Sci., 10, 621, 10.1007/s10989-004-2433-4 · DOI
  137. Sakiyama, 2001, pH-sensitive shrinking of a dextran sulfate/chitosan complex gel and its promotion effect on the release of polymeric substances, J. Appl. Polym. Sci., 81, 667, 10.1002/app.1483 · DOI
  138. Sarmento, 2007, Oral bioavailability of insulin contained in polysaccharide nanoparticles, Biomacromolecules, 8, 3054, 10.1021/bm0703923 · DOI
  139. Bugnicourt, 2016, Interests of chitosan nanoparticles ionically cross-linked with tripolyphosphate for biomedical applications, Prog. Polym. Sci., 60, 1, 10.1016/j.progpolymsci.2016.06.002 · DOI
  140. Hosseini, 2018, Chitosan/sodium tripolyphosphate nanoparticles as efficient vehicles for antioxidant peptidic fraction from common kilka, Int. J. Biol. Macromol., 111, 730, 10.1016/j.ijbiomac.2018.01.023 · DOI
  141. Wu, 2017, Preparation and biological activity studies of resveratrol loaded ionically cross-linked chitosan-TPP nanoparticles, Carbohydr. Polym., 175, 170, 10.1016/j.carbpol.2017.07.058 · DOI
  142. Dmour, 2017, Novel nanoparticles based on chitosan-dicarboxylate conjugates via tandem ionotropic/covalent crosslinking with tripolyphosphate and subsequent evaluation as drug delivery vehicles, Int. J. Pharm., 529, 15, 10.1016/j.ijpharm.2017.06.061 · DOI
  143. Koukaras, 2012, Insight on the formation of chitosan nanoparticles through ionotropic gelation with tripolyphosphate, Mol. Pharm., 9, 2856, 10.1021/mp300162j · DOI
  144. Prego, 2010, Chitosan-based nanoparticles for improving immunization against hepatitis B infection, Vaccine, 28, 2607, 10.1016/j.vaccine.2010.01.011 · DOI
  145. Oliveira, 2017, Microparticles prepared with 50–190 kDa chitosan as promising non–toxic carriers for pulmonary delivery of isoniazid, Carbohydr. Polym., 174, 421, 10.1016/j.carbpol.2017.06.090 · DOI
  146. De Campos, 2001, Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface, Application to cyclosporin A, Int. J. Pharm., 224, 159, 10.1016/S0378-5173(01)00760-8 · DOI
  147. Jain, 2016, Fabrication, characterization and cytotoxicity studies of ionically cross–linked docetaxel loaded chitosan nanoparticles, Carbohydr. Polym., 137, 65, 10.1016/j.carbpol.2015.10.012 · DOI
  148. Xu, 2003, Preparation and modification of N-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride nanoparticle as a protein Carrier, Biomaterials, 24, 5015, 10.1016/S0142-9612(03)00408-3 · DOI
  149. Zhang, 2010, Preparation and characterization of water–soluble chitosan nanoparticles as protein delivery system, J. Nanomater., 2010, 1, 10.1155/2010/898910 · DOI
  150. Ramasamy, 2017, Smart chemistry-based nanosized drug delivery systems for systemic applications: a comprehensive review, J. Contr. Release, 258, 226, 10.1016/j.jconrel.2017.04.043 · DOI
  151. Cánepa, 2017, Development of a drug delivery system based on chitosan nanoparticles for oral administration of interferon-α, Biomacromolecules, 18, 3302, 10.1021/acs.biomac.7b00959 · DOI
  152. Wang, 2017, Mechanoresponsive materials for drug delivery: harnessing forces for controlled release, Adv. Drug Deliv. Rev., 108, 68, 10.1016/j.addr.2016.11.001 · DOI · Paper page
  153. Wilczewska, 2012, Nanoparticles as drug delivery systems, Pharmacol, For. Rep., 64, 1020
  154. Wais, 2016, Drug nanoparticles by emulsion–freeze–drying via the employment of branched block copolymer nanoparticles, J. Contr. Release, 222, 141, 10.1016/j.jconrel.2015.12.022 · DOI
  155. Goyal, 2016, Nanoparticles and nanofibers for topical drug delivery, J. Contr. Release, 240, 77, 10.1016/j.jconrel.2015.10.049 · DOI
  156. Cho, 2008, Therapeutic nanoparticles for drug delivery in cancer, Clin. Canc. Res., 14, 1310, 10.1158/1078-0432.CCR-07-1441 · DOI
  157. Chen, 2015, Hierarchical targeted hepatocyte mitochondrial multifunctional chitosan nanoparticles for anticancer drug delivery, Biomaterials, 52, 240, 10.1016/j.biomaterials.2015.02.001 · DOI
  158. Li, 2015, Polymeric drugs: advances in the development of pharmacologically active polymers, J. Contr. Release, 219, 369, 10.1016/j.jconrel.2015.09.043 · DOI
  159. Van Vlerken, 2007, Poly (ethylene glycol)–modified nanocarriers for tumor–targeted and intracellular delivery, Pharm. Res., 24, 1405, 10.1007/s11095-007-9284-6 · DOI
  160. Shenoy, 2005, Poly (ethylene oxide)–modified poly (ɛ–caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer, Int. J. Pharm., 293, 261, 10.1016/j.ijpharm.2004.12.010 · DOI
  161. Beck–Broichsitter, 2012, Controlled pulmonary drug and gene delivery using polymeric nano–carriers, J. Contr. Release, 161, 214, 10.1016/j.jconrel.2011.12.004 · DOI · Paper page
  162. Keraliya, 2012, Osmotic drug delivery system as a part of modified release dosage form, ISRN Pharm., 2012
  163. Fu, 2010, Drug release kinetics and transport mechanisms of non–degradable and degradable polymeric delivery systems, Expert Opin, Drug Deliv., 7, 429
  164. Birajdar, 2016, Sonication-triggered zero-order release by uncorking core–shell nanofibers, Chem. Eng. J., 288, 1, 10.1016/j.cej.2015.11.095 · DOI
  165. Unagollaand, 2018, Drug transport mechanisms and in vitro release kinetics of vancomycin encapsulated chitosan-alginate polyelectrolyte microparticles as a controlled drug delivery system, Eur. J. Pharmaceut. Sci., 114, 199, 10.1016/j.ejps.2017.12.012 · DOI
  166. Tan, 2016, Polysaccharide-based nanoparticles by chitosan and gum Arabic polyelectrolyte complexation as carriers for curcumin, Food Hydrocolloids, 57, 236, 10.1016/j.foodhyd.2016.01.021 · DOI
  167. Song, 2017, Carboxymethyl-β-cyclodextrin grafted chitosan nanoparticles as oral delivery Carrier of protein drugs, React. Funct. Polym., 117, 10, 10.1016/j.reactfunctpolym.2017.05.008 · DOI

Cited by

Sorted by citations

Metadata

Authors
Safdar, R., Omar, A. A., Arunagiri, A., Regupathi, I., & Thanabalan, M.
Venue
Journal of Drug Delivery Science and Technology
Publisher
Elsevier BV
Published
2019-02
Volume
49
Pages
642-659
ISSN
1773-2247
DOI
10.1016/j.jddst.2018.10.020
Cited by
147
References
0
Language
en
Licence
Funders
Universiti Teknologi Petronas

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review